BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

477 related articles for article (PubMed ID: 23521674)

  • 1. Do other Hypericum species have medical potential as St. John's wort (Hypericum perforatum)?
    Stojanović G; Ðorđević A; Šmelcerović A
    Curr Med Chem; 2013; 20(18):2273-95. PubMed ID: 23521674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypericum perforatum (St John's wort) beyond depression: A therapeutic perspective for pain conditions.
    Galeotti N
    J Ethnopharmacol; 2017 Mar; 200():136-146. PubMed ID: 28216196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of new and validated HPTLC methods for the qualitative and quantitative analysis of hyperforin, hypericin and hyperoside contents in Hypericum species.
    Saçıcı E; Yesilada E
    Phytochem Anal; 2022 Apr; 33(3):355-364. PubMed ID: 34734668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical application of St. John's wort (Hypericum perforatum).
    Wölfle U; Seelinger G; Schempp CM
    Planta Med; 2014 Feb; 80(2-3):109-20. PubMed ID: 24214835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolomic and chemometric analyses of St. John's wort and related Asian Hypericum species linked to bioactivity.
    Ji Y; Zhang R; Bensalel J; Morcol T; Gu R; Gallego-Delgado J; Kennelly EJ; Long C
    J Ethnopharmacol; 2024 Jul; 329():118163. PubMed ID: 38588986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypericum perforatum: a 'modern' herbal antidepressant: pharmacokinetics of active ingredients.
    Wurglics M; Schubert-Zsilavecz M
    Clin Pharmacokinet; 2006; 45(5):449-68. PubMed ID: 16640452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New Potential Pharmaceutical Applications of Hypericum Species.
    Marrelli M; Statti G; Conforti F; Menichini F
    Mini Rev Med Chem; 2016; 16(9):710-20. PubMed ID: 26156546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of action of St John's wort in depression : what is known?
    Butterweck V
    CNS Drugs; 2003; 17(8):539-62. PubMed ID: 12775192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hypericin and hyperforin: bioactive components of St. John's Wort (Hypericum perforatum). Their isolation, analysis and study of physiological effect].
    Vacek J; Klejdus B; Kubán V
    Ceska Slov Farm; 2007 Apr; 56(2):62-6. PubMed ID: 17619301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review of the antibacterial activity of Hypericum perforatum L.
    Saddiqe Z; Naeem I; Maimoona A
    J Ethnopharmacol; 2010 Oct; 131(3):511-21. PubMed ID: 20659547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High performance liquid chromatography/electrospray mass spectrometry of Hypericum perforatum extracts.
    Mauri P; Pietta P
    Rapid Commun Mass Spectrom; 2000; 14(2):95-9. PubMed ID: 10623936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phytochemical analysis of nine Hypericum L. species from Serbia and the F.Y.R. Macedonia.
    Smelcerovic A; Spiteller M
    Pharmazie; 2006 Mar; 61(3):251-2. PubMed ID: 16599273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of anti-inflammatory constituents in Hypericum perforatum and Hypericum gentianoides extracts using RAW 264.7 mouse macrophages.
    Huang N; Rizshsky L; Hauck C; Nikolau BJ; Murphy PA; Birt DF
    Phytochemistry; 2011 Nov; 72(16):2015-23. PubMed ID: 21855951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro photochemical and phototoxicological characterization of major constituents in St. John's Wort (Hypericum perforatum) extracts.
    Onoue S; Seto Y; Ochi M; Inoue R; Ito H; Hatano T; Yamada S
    Phytochemistry; 2011 Oct; 72(14-15):1814-20. PubMed ID: 21782201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro receptor screening of pure constituents of St. John's wort reveals novel interactions with a number of GPCRs.
    Butterweck V; Nahrstedt A; Evans J; Hufeisen S; Rauser L; Savage J; Popadak B; Ernsberger P; Roth BL
    Psychopharmacology (Berl); 2002 Jul; 162(2):193-202. PubMed ID: 12110997
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Marrelli M; Statti G; Conforti F
    Mini Rev Med Chem; 2020; 20(1):66-87. PubMed ID: 31556858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positive correlations between hypericin and putative precursors detected in the quantitative secondary metabolite spectrum of Hypericum.
    Kusari S; Zühlke S; Borsch T; Spiteller M
    Phytochemistry; 2009 Jul; 70(10):1222-32. PubMed ID: 19683774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypericin and pseudohypericin concentrations of a valuable medicinal plant Hypericum perforatum L. are enhanced by arbuscular mycorrhizal fungi.
    Zubek S; Mielcarek S; Turnau K
    Mycorrhiza; 2012 Feb; 22(2):149-56. PubMed ID: 21626142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preserved pharmacological activity of hepatocytes-treated extracts of valerian and St. John's wort.
    Simmen U; Saladin C; Kaufmann P; Poddar M; Wallimann C; Schaffner W
    Planta Med; 2005 Jul; 71(7):592-8. PubMed ID: 16041642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. St. John's wort extracts and some of their constituents potently inhibit ultimate carcinogen formation from benzo[a]pyrene-7,8-dihydrodiol by human CYP1A1.
    Schwarz D; Kisselev P; Roots I
    Cancer Res; 2003 Nov; 63(22):8062-8. PubMed ID: 14633740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.